We don't have a scalable cure for sickle cell disease available to most patients who need it.
open
Global / Unspecified, Africa
WS00463
Emerging gene therapies show promise but remain extremely expensive and inaccessible to the vast majority of people living with sickle cell disease worldwide, especially in Africa where it's most common. Making a real cure affordable and available remains unsolved.